Modern Care for Menopause
Targeted hormone support
Rethinking Hormone Replacement Therapy
For years, many women were told that hormone replacement therapy (HRT) was too risky to consider for menopause symptoms. This view came largely from early interpretations of the Women’s Health Initiative (WHI) study in the early 2000s, which appeared to show increased risks of breast cancer, stroke, and heart disease with HRT use.
Over time, researchers have re-evaluated this data. It is now widely recognized that the WHI findings were misinterpreted, especially for women who started HRT earlier in their menopausal journey.
The New Menopause Era: What the Research Shows
Current evidence suggests that when HRT is started at the right time — during perimenopause or early menopause — it can offer significant health benefits:
- Bone Health: Reduces risk of osteoporosis and fractures.
- Cardiac Protection: Supports heart and vascular health when started early.
- Mental Health: Can improve mood, cognitive clarity, and lower risk of depression.
- Genitourinary Health: Effectively treats urinary urgency, dryness, and painful intercourse.
- Overall Quality of Life: Improves sleep, hot flashes, night sweats, and daily function.
The key is timing: HRT works best when introduced as symptoms begin, not years after menopause has passed.
Our Approach
At Lumina, we believe menopause care should be personalized — not one-size-fits-all. That’s why our program includes:
- Extensive Intake Consultation: A full review of your health history, current symptoms, and goals.
- Customized Management Plan: Tailored strategies combining HRT, lifestyle recommendations, and supportive therapies.
- Comprehensive Evaluation: Ordering customized lab work and diagnostic tests to rule out other causes of your symptoms.
- Holistic Care: Referrals to trusted specialists in mental health, cardiology, bone health, and more, so every aspect of your midlife health is supported.
- Certified Expertise: Care provided by two Menopause Society Certified Providers, ensuring your treatment is guided by the most up-to-date science and safety standards.
I am in my 60s. Is it too late to start hormone therapy?
There’s no specific age that makes hormone therapy unsafe.
What matters most is timing and your health profile. Hormone therapy is generally safest when started within 10 years of menopause, and risks may increase if begun much later. Your individual factors — such as cardiovascular health, personal and family history of breast cancer, and your goals for treatment (like bone support or relief from hot flashes) — all play an important role in determining whether hormone therapy is a good fit. It shouldn’t be used to prevent heart disease, dementia, or aging. Your clinician will help you weigh benefits and risks to determine whether it’s the right choice for you.
Is there evidence that starting hormone therapy in perimenopause can prevent menopause or chronic diseases?
No, HRT cannot “prevent” menopause or chronic disease.
In perimenopause, hormone therapy may help with symptoms but is not strong enough to prevent pregnancy or reliably manage heavy menstrual bleeding. For contraception or bleeding control, options like a progestin IUD or a low-dose hormonal pill, patch, or ring may be appropriate and can be paired with symptom management as needed.
Are there different indicators for the use of systemic and vaginal estrogen?
Yes, vaginal estrogen and systemic estrogen treat different symptoms.
Low-dose vaginal estrogen is used to relieve genitourinary symptoms such as vaginal dryness, irritation, discomfort with sexual activity, and urinary urgency or frequency. It may also help reduce recurrent urinary tract infections in postmenopausal women.
Systemic estrogen is FDA-approved for hot flashes and night sweats, prevention of bone loss, and may also support sleep and mood.
While systemic estrogen can help with genitourinary symptoms, vaginal estrogen is preferred when these are the only concerns. If someone is already on systemic hormone therapy but still has genitourinary symptoms, adding low-dose vaginal estrogen may be beneficial.
Should hormone therapy be used to prevent heart disease?
No, HRT is not recommended to prevent cardiovascular disease.
Its effects on heart health depend largely on when it’s started. Beginning hormone therapy within 10 years of menopause may have some favorable effects on coronary heart disease and overall mortality, but these must be balanced against small increases in risks such as breast cancer, blood clots, and stroke.
Starting hormone therapy 20–30 years after menopause is associated with higher risks of heart disease, blood clots, and stroke, and is generally not advised.
Your clinician can help you determine whether hormone therapy is appropriate based on your age, timing, and overall health.
Should hormone therapy be used to prevent dementia?
No, HRT is not recommended to prevent or treat cognitive decline or dementia.
For women who reach menopause at the typical age, current evidence does not show that hormone therapy protects against dementia.
There may be cognitive benefits when hormone therapy is started in women who experience early menopause due to hysterectomy and oophorectomy. However, starting certain hormone regimens after age 65 — such as conjugated equine estrogen with medroxyprogesterone acetate — was associated with an increased risk of dementia.
Your clinician can help determine whether hormone therapy is appropriate based on your age, timing, and health history.
Should hormone therapy be used for weight loss?
No, HRT may improve body composition, but it does not typically lead to weight loss.
Higher body fat, especially around the abdomen, is linked to more severe menopausal symptoms. Weight loss through lifestyle changes has been shown to reduce the frequency and intensity of hot flashes, but weight-loss medications have only limited impact on these symptoms.
Early research suggests hormone therapy might enhance the effects of weight-loss medications, but the evidence is preliminary and not yet strong enough to guide routine clinical care.
Does hormone therapy prevent bone loss and protect against fracture risk?
Yes, HRT is FDA-approved for the prevention of bone loss.
It helps maintain bone density and lowers fracture risk in healthy postmenopausal women, with benefits increasing at higher doses. However, hormone therapy is not approved for treating established osteoporosis, and other treatments are usually recommended for women who already meet osteoporosis criteria.
Stopping hormone therapy can lead to a period of accelerated bone loss and a temporary increase in fracture risk, though some long-term protection may remain.
For women with premature menopause, hormone therapy is recommended (unless contraindicated) to protect bone health until they reach the average age of natural menopause, when treatment can be reassessed.
A New Chapter for Women's Health
We are proud to be part of the new menopause era — one where women are seen as whole individuals, not just data points in outdated studies. Our mission is to provide safe, evidence-based, and compassionate care that empowers you to thrive in midlife and beyond.